QuiVad

Home / France / Emeis

Emeis

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 14.06% on February 1, 2023. The shaded band is the year shown above.

June 5, 2014 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

History of disclosures

638 disclosures on record for this share.
DateFund% of capitalEnd of publication
July 18, 2023Helikon Investments Limited4.78%December 8, 2023
July 18, 2023Astaris Capital Management LLP1.00%October 3, 2023
July 14, 2023Astaris Capital Management LLP1.16%October 3, 2023
July 13, 2023Astaris Capital Management LLP1.23%October 3, 2023
July 12, 2023Astaris Capital Management LLP1.36%October 3, 2023
July 11, 2023Helikon Investments Limited4.89%December 8, 2023
June 26, 2023Helikon Investments Limited4.96%December 8, 2023
June 26, 2023Whitebox Advisors LLC0.70%October 25, 2023
June 2, 2023Helikon Investments Limited5.08%December 8, 2023
June 2, 2023Immersion Capital Master Fund LTD0.00%June 6, 2023
June 1, 2023Immersion Capital Master Fund LTD0.58%June 6, 2023
May 31, 2023Astaris Capital Management LLP1.51%October 3, 2023
May 31, 2023Whitebox Advisors LLC0.60%October 25, 2023
May 31, 2023Qube Research & Technologies Limited0.48%June 2, 2023
May 30, 2023Helikon Investments Limited5.27%December 8, 2023
May 30, 2023Astaris Capital Management LLP1.80%October 3, 2023
May 29, 2023Helikon Investments Limited5.38%December 8, 2023
May 26, 2023Astaris Capital Management LLP2.12%October 3, 2023
May 23, 2023Helikon Investments Limited5.42%December 8, 2023
May 18, 2023Qube Research & Technologies Limited1.10%June 2, 2023
May 15, 2023Qube Research & Technologies Limited1.08%June 2, 2023
May 9, 2023Qube Research & Technologies Limited1.11%June 2, 2023
May 8, 2023Qube Research & Technologies Limited1.07%June 2, 2023
May 2, 2023Qube Research & Technologies Limited1.10%June 2, 2023
April 27, 2023Qube Research & Technologies Limited1.08%June 2, 2023
April 26, 2023Qube Research & Technologies Limited1.10%June 2, 2023
April 25, 2023Helikon Investments Limited5.58%December 8, 2023
April 24, 2023Qube Research & Technologies Limited1.05%June 2, 2023
April 21, 2023Qube Research & Technologies Limited0.94%June 2, 2023
April 20, 2023Qube Research & Technologies Limited1.07%June 2, 2023
April 19, 2023Qube Research & Technologies Limited1.41%June 2, 2023
April 18, 2023Helikon Investments Limited5.69%December 8, 2023
April 18, 2023Qube Research & Technologies Limited1.35%June 2, 2023
April 17, 2023Qube Research & Technologies Limited1.15%June 2, 2023
April 14, 2023Qube Research & Technologies Limited0.97%June 2, 2023
April 13, 2023Helikon Investments Limited5.73%December 8, 2023
April 12, 2023Qube Research & Technologies Limited0.83%June 2, 2023
April 11, 2023Qube Research & Technologies Limited0.79%June 2, 2023
April 4, 2023Helikon Investments Limited5.89%December 8, 2023
March 30, 2023Qube Research & Technologies Limited1.08%June 2, 2023
March 28, 2023Qube Research & Technologies Limited1.21%June 2, 2023
March 27, 2023Qube Research & Technologies Limited1.32%June 2, 2023
March 21, 2023Qube Research & Technologies Limited1.41%June 2, 2023
March 20, 2023Qube Research & Technologies Limited1.35%June 2, 2023
March 17, 2023Astaris Capital Management LLP2.60%October 3, 2023
March 16, 2023Qube Research & Technologies Limited1.24%June 2, 2023
March 15, 2023Qube Research & Technologies Limited1.13%June 2, 2023
March 14, 2023Qube Research & Technologies Limited0.95%June 2, 2023
March 14, 2023Pictet Asset Management Limited0.35%March 16, 2023
March 13, 2023Astaris Capital Management LLP2.55%October 3, 2023

Other companies sold short in France

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Emeis, source AMF, data as at July 30, 2026, https://www.quivad.com/action/emeis?page=3